100120

Vieworks develops, manufactures, and sells imaging solutions, primarily X-ray detectors and industrial cameras. The company operates two main business segments: medical imaging solutions and industrial imaging solutions. In the medical segment, it produces static and dynamic X-ray detectors, including flat panel detectors for digital radiography, fluoroscopy, angiography, and dental applications, as well as a high-resolution digital slide scanner for pathology. In the industrial segment, it supplies high-resolution area-scan and line-scan cameras for machine vision applications, such as automatic optical inspection (AOI) for flat panel displays, semiconductors, and PCBs, as well as cameras for golf simulators and industrial CT inspection. Vieworks serves customers globally, including system manufacturers in the Americas, Europe, and Asia, and major electronics and semiconductor manufacturers in Korea, China, and Japan. The company sells medical products directly to OEMs and through distributors, while industrial products are primarily sold via regional distributors and ODM partners. Notable product lines include the VIVIX series for X-ray detectors, the VN and VP series for industrial cameras, and the VISQUE series for in vivo imaging and digital pathology.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Devices Homepage vieworks.com
Sector Healthcare IR page vieworks.com
Tags
x-ray detectors, industrial cameras, machine vision, digital pathology, flat panel detectors, area-scan cameras, line-scan cameras, medical imaging, automatic optical inspection, in vivo imaging, VIVIX-S, VIVIX-D, VIVIX-V, VIVIX-M, VN Series, VP-152MX2, VQ Series, VTC Series, VISQUE in vivo Art, VISQUE Smart-LF, VISQUE DPS LH210, VXvue, QXR-Series, Slimpac RF, Maxxray, RXDM-0405
Press page —

Metrics

Valuation  
Market cap —
Market cap (USD) —
P/E —
PEG —
P/BV —
P/S —
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 9.0%
ROI 8.8%
ROIC 7.1%
Profit margin 9.2%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -6.1%
Quality  
Profitable Yes
Margin expanding No
Buying back stock —
Diluting (TTM) —
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) —
Quality score 36.4%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 239.335B 222.898B 220.251B 237.929B 193.139B 160.264B 136.01B 131.404B 123.461B 117.303B 93.439B 70.811B 66.501B
Net profit 21.971B 21.297B 14.715B 26.539B 33.474B 22.893B 24.216B 20.771B 19.631B 26.979B 15.897B 10.48B 9.466B
Free cash flow 8.232B 7.447B 10.272B -14.93B 10.734B -16.918B 10.572B 18.452B 16.2B 16.161B 16.351B -8.746B 3.357B

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (KRW) 25.8B 23.1B 22.9B 22B 25.2B 35.1B 43.5B 45.5B 45.6B 56.6B
↳ YoY growth +52.1% -10.2% -0.9% -4.0% +14.6% +39.2% +23.9% +4.5% +0.2% +24.3%
↳ 5y CAGR +18.6% +15.5% +8.3% +6.4% +13.5% +14.7% +15.7% +17.6%
Borrowings, current (KRW) 1.2B 358M 403M 1.7B 8B 21B 50B 50.9B 36.3B 66.8B
Borrowings, non-current (KRW) 300M 0.00 0.00 — — — — 250M 18.1B 203M
Cash and deposits (KRW) 34.8B 37.3B 46.5B 53.1B 39.6B 41.5B 41B 40.8B 28.2B 29.6B
Intangible assets (KRW) 2.98B 3.15B 6.09B 6.4B 6.39B 6.14B 6.79B 9.72B 8.38B 7.78B
Net debt (borrowings + leases - cash) (KRW) -33.3B -36.9B -46.1B -51.4B -31.6B -20.4B 8.98B 10.4B 26.2B 37.4B
Cash flow detail
Operating cash flow (KRW) 19.9B 18.9B 27.8B 18.7B 6.29B 16.2B -1.5B 23.3B 35.6B 37.2B
Purchases of property, plant and equipment (KRW) -3.74B -2.65B -9.38B -8.11B -23.2B -5.43B -13.4B -13B -28.1B -29B
Purchases of intangible assets (KRW) -246M -1.92B -348M -1.27B -495M -762M -1.54B -2.17B -829M -446M
Dividends paid (cash effect) (KRW) -999M -2B -1.99B -2.96B -3.94B -4.25B -6.89B -6.43B -3.21B -5.51B
Share buybacks (cash effect) (KRW) -566M -2.03B -2.78B — -9.07B -10.9B — 0.00 0.00 -4.99B
Interest paid (cash effect) (KRW) -7.88M — -51.7M -57.1M -23.2M -343M -1.03B -2.31B -2.35B -1.18B
Income taxes paid (cash effect) (KRW) -4.18B -7.24B -3.55B -4.6B -6.93B -3.88B -11.2B -6.88B -1.87B -4.81B
Free cash flow (OCF - PPE - intangibles) (KRW) 15.9B 14.3B 18.1B 9.3B -17.4B 9.97B -16.5B 8.1B 6.62B 7.79B
Income detail
Total comprehensive income (KRW) 27.2B 19.8B 20.5B 23.7B 21.9B 33B 28B 12.9B 24.4B 22.1B
Comprehensive income to owners (KRW) 27.3B 19.9B 20.5B 23.6B 21.9B 33B 28.1B 12.8B 24.6B 23.2B
Reported Mar 31, 2017 Mar 30, 2018 Mar 29, 2019 Mar 30, 2020 Mar 18, 2021 Mar 20, 2024 Mar 20, 2024 Mar 23, 2026 Mar 23, 2026 Mar 23, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

2026-08-21

Vieworks, a global imaging solution provider, has set a target of capturing more than 8% of the global digital pathology market within five years through slide scanners optimized for AI-based diagnostics.

Speaking at the Digital Pathology AX (AI Transformation) Conference during K-HOSPITAL + HEALTH TECH FAIR 2026 on Aug. 20, the company said it has begun embedding image pre-processing AI in its VISQUE DPS slide scanner and is preparing for commercialization, with plans to expand supply across North America, Europe and Asia.

Slide scanners serve as the data entry point for AI analysis. A focus deviation of only 1 to 2 micrometers during image acquisition can degrade AI model performance by 5 to 10%. Vieworks developed a deep learning-based scan area detection AI that identifies non-tissue regions such as pen markings, dust and air bubbles at the pixel level, filtering out areas that cause focus errors. 

The company reported 99% focus alignment and a focus error rate below 1% in non-tissue regions, reducing re-scans. Technology also maintains focus reproducibility in cytology specimens, where cell overlap and thickness variation are common.

Vieworks is also developing a predictive maintenance AI that continuously monitors robotic arm slide transport through imaging to anticipate faults, supporting uninterrupted high-volume processing in unattended operation.

The presentation also covered Realtime Extended Focus, which acquires three images at different focal planes using three cameras simultaneously and fuses them in real time into a single fully focused image. Vieworks has filed or registered more than 20 patents related to the technology in Korea, the United States, Europe and Japan.

Deployment cases presented included Pennsylvania Dermatology Group in the United States, Ankara Bilkent City Hospital in Türkiye, and several hospitals in Korea.

The company plans to expand its lineup with a compact fluorescence scanner for space-constrained environments and a multi-channel fluorescence scanner for research applications such as spatial biology.

"As AI use expands in pathology, scanners are expected to go beyond image acquisition and produce precise, standardized data that AI can rely on." said Kang Yu-jung, head of the Bio Business Group at Vieworks.

--------------

Vieworks' Digital Pathology System Information

2026-08-04

Vieworks, a leading provider of medical and industrial solutions, reported preliminary consolidated results for the first half of 2026, with revenue of 122 billion won and operating profit of 19.5 billion won, up 4.2% and 127.4% respectively from a year earlier.

"Global expansion in semiconductor inspection equipment investment was reflected in our machine vision results," a Vieworks spokesperson said.

Medical imaging solutions generated about 91.8 billion won, in line with the prior year. Revenue from dynamic X-ray detectors for dental system customers in Europe recovered from a year earlier.

Industrial imaging solutions, or machine vision cameras, generated about 30.2 billion won, up 24.6%. Demand for cameras used in semiconductor inspection equipment recovered, and sales of customer-specific models centered on TDI line scan cameras expanded. In the second half, the company plans to continue developing products with fiber-optic high-speed interfaces.

In new businesses, the digital pathology slide scanner has moved from supply agreements with customers in the United States and Europe to a Korean pathology society exhibition and demonstrations at major domestic hospitals. The company is reviewing entry into Asian markets.

In the golf segment, covering sensors and launch monitors, Vieworks began full-scale supply of launch monitors to NVisage, a U.S. golf imaging brand, alongside its existing ODM business.

Prompts

Vieworks (ticker 100120), listed in South Korea.

ETFs Holding Vieworks

ETF Weight in ETF Shares Market value As of
DFEV 0.00% 5,069 $ 104.394K Nov 12, 2026
DFSE 0.00% 625 $ 12.872K Nov 12, 2026
DFAE 0.00% 5,277 $ 108.677K Nov 12, 2026
DFEM 0.00% 3,618 $ 74.511K Nov 12, 2026
DFAX 0.00% 4,125 $ 84.952K Nov 12, 2026
DEXC 0.00% 20 $ 411.89 Nov 12, 2026
AVEM 0.00% 968 $ 20.154K Nov 16, 2026